Literature DB >> 9880117

Endocrine causes of hypertension in pregnancy--when to start looking for zebras.

E Keely1.   

Abstract

Hypertension is a common medical disorder in pregnancy that may predate or first appear in pregnancy. Endocrine disorders rarely are the cause of the elevated blood pressure. However, it is essential to have a high index of suspicion because they carry much higher fetal and maternal morbidity and mortality risks. Endocrine disorders presenting as hypertension are primarily the result of autonomous production of renin, aldosterone, cortisol, or catecholamines. This report discusses the physiological changes in pregnancy, presentation, investigation, and management of these disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9880117     DOI: 10.1016/s0146-0005(98)80027-x

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  5 in total

Review 1.  Management of urological cancers during pregnancy.

Authors:  Makarand V Khochikar
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

Review 2.  Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases.

Authors:  Marta Araujo-Castro; Lía Nattero Chavez; Alberto Martínez Lorca; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Eider Pascual-Corrales
Journal:  Clin Exp Med       Date:  2021-09-30       Impact factor: 5.057

Review 3.  Endocrine causes of hypertension in pregnancy.

Authors:  Alison H Affinati; Richard J Auchus
Journal:  Gland Surg       Date:  2020-02

4.  Management of paroxysmal hypertension due to incidental pheochromocytoma in pregnancy.

Authors:  Indu Lata; Sandeep Sahu
Journal:  J Emerg Trauma Shock       Date:  2011-07

5.  Pregnancy rest-activity patterns are related to salivary cortisol rhythms and maternal-fetal health indicators in women from a disadvantaged population.

Authors:  Theresa Casey; Hui Sun; Aridany Suarez-Trujillo; Jennifer Crodian; Lingsong Zhang; Karen Plaut; Helen J Burgess; Shelley Dowden; David M Haas; Azza Ahmed
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.